Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in coronary perivascular inflammation (COPIX)
NCT05347316Phase 1Unknown
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Mar 2022
- Primary completion
- Mar 2023
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in atherosclerosis and coronary artery disease (CAD) comparing Colchicine with Placebo (2 arms). Primary endpoint: Fat Attenuation Index at 12 months. Status: unknown.
02
Drugs
colchicine
03
Conditions
atherosclerosiscoronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05347316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05347316.